Multiple Assemblies exist for SMTL entry 6qu2
Crystal structure of DYRK1A complexed with FC162 inhibitor; X-RAY DIFFRACTION 2.90 Å

	SMTL ID 6qu2.1 Ligands SULFATE ION; TETRAETHYLENE GLYCOL; DIMETHYL SULFOXIDE; 8-cyclopropyl-2-pyridin-3-yl-[1,3]thiazolo[5,4-f]quinazolin-9-one Polypeptides Dual specificity tyrosine-phosphorylation-regulated kinase 1A Oligo-state monomer
	SMTL ID 6qu2.2 Ligands SULFATE ION; TETRAETHYLENE GLYCOL; DIMETHYL SULFOXIDE; 8-cyclopropyl-2-pyridin-3-yl-[1,3]thiazolo[5,4-f]quinazolin-9-one Polypeptides Dual specificity tyrosine-phosphorylation-regulated kinase 1A Oligo-state monomer
	SMTL ID 6qu2.3 Ligands SULFATE ION; TETRAETHYLENE GLYCOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 8-cyclopropyl-2-pyridin-3-yl-[1,3]thiazolo[5,4-f]quinazolin-9-one Polypeptides Dual specificity tyrosine-phosphorylation-regulated kinase 1A Oligo-state monomer
	SMTL ID 6qu2.4 Ligands SULFATE ION; TETRAETHYLENE GLYCOL; 8-cyclopropyl-2-pyridin-3-yl-[1,3]thiazolo[5,4-f]quinazolin-9-one Polypeptides Dual specificity tyrosine-phosphorylation-regulated kinase 1A Oligo-state monomer